Consumer Healthcare Market by Product, Distribution Channel, and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 164 SKU: IRTNTR73381

Consumer Healthcare Market Forecast 2023-2027

The global consumer healthcare market is estimated to grow by USD 189.13 billion at a CAGR of 7.84% between 2022 and 2027. Consumer healthcare products, available over-the-counter at pharmacy stores without a prescription, facilitate increased usage and self-medication practices. Individuals with mild conditions like gastrointestinal issues opt for related medications, alleviating pressure on medical professionals and facilities. Particularly beneficial for patients in rural areas with limited healthcare access, responsible self-medication aids in monitoring mild ailments, propelling the global consumer healthcare market's growth.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

The consumer healthcare market encompasses a diverse range of products, from personal healthcare products and cosmetics to disinfectants and consumer medical devices. Addressing various healthcare needs, it includes nutraceuticals, OTC goods, and preventative medicine. Governed by government regulations on drug distribution, it offers solutions such as analgesics, cold, cough & flu products, and weight loss products. With a focus on wellness and nutrition, it caters to oral health and skin health, meeting the demand for health supplements and medicines through retail and digital health channels while combatting issues like counterfeit drugs. This global consumer healthcare market continues to evolve, driven by value and the pursuit of a healthier lifestyle.

Market Segmentation

Technavio has segmented the market into  Product (OTC pharmaceuticals and dietary supplements ), Distribution Channel (offline and online ), and Geography (North America, Asia, Europe, and the rest of world (ROW)).  In the realm of healthcare, oral health and skin health stand as vital aspects often supported by accessible over the counter (OTC) drugs and patient-centric treatments. Balancing healthcare costs against the benefits of wellness & preventive medicine becomes increasingly important, especially in the face of rising concerns about mental health and the prevalence of age-related diseases. Alongside addressing digestive diseases and muscle pain, initiatives such as advertising campaigns promote awareness, offering customized products tailored to individual needs, available through various channels including online sources, branded products, and private labels. This multifaceted approach aligns with the objectives outlined by the World Health Organization (WHO), advocating for comprehensive healthcare solutions.

By Product

The industry share growth by the OTC pharmaceuticals segment will be significant during the forecast period. OTC drugs can be bought without a doctor's prescription, as regulatory agencies such as the US Food and Drug Administration (FDA) have declared them to be safe for use without medical supervision. These drugs are used to treat conditions and symptoms such as pain, itchiness of the skin, cough and cold, sleeping problems, gastrointestinal problems, and tooth decay.

Get a glance at the market contribution of various segments View the PDF Sample

The OTC pharmaceuticals segment was valued at USD 227.92 billion in 2017 and continued to grow until 2021. OTC drugs are sold off-the-shelf in pharmacies, hypermarkets, supermarkets, or other distribution channels. The safety and efficacy standards are similar for OTC and prescription drugs. The bioequivalence of OTC drugs should also be on par with that of prescription drugs. This enables consumers to diagnose, treat, and manage mild disorders or symptoms on their own. Thus, the OTC pharmaceuticals segment will witness growth during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The growth of the market in North America is driven by factors such as the surge in the prevalence of skin diseases, rapid technological advances in the pharmaceutical sector, and the growth of the geriatric population. Consumers in the region are focusing on healthy diets owing to improved awareness about the nutritional content of food products and the large-scale promotional activities carried out by dietary supplement manufacturers, trade organizations, and medical institutions. This has resulted in high penetration of consumer healthcare products such as dietary supplements and OTC pharmaceuticals in the US and Canada. The consumption of dietary supplements in the region is expected to increase during the forecast period due to a rise in the demand for dietary and nutritional food products among Millennials. Consumers in the region are more inclined toward organic and natural dietary products that supplement natural nutrients, which has spurred the consumption of herbal and plant-based dietary supplements. They also prefer to procure dietary supplements through online distribution channels, which helps them compare products and their properties before making a decision. Internet and smartphone penetration is high in North America, which has increased the use of e-commerce for buying dietary supplements. All these factors will drive the growth of the regional market during the forecast period. 

Market Dynamics

The global consumer healthcare market is experiencing rapid growth, driven by a burgeoning interest in personal health and wellness. This trend has reshaped the healthcare industry, with consumers increasingly seeking preventive and self-care solutions. From pain relief medications to nutrition supplements and wellness products, there's a growing demand for a wide array of health improvement options. Innovation, including advancements in tech wearables and digital health tools, further propels market expansion.

Particularly in light of the pandemic, there's a heightened reliance on online platforms and telehealth services to address health needs and bridge gaps in traditional healthcare infrastructure. Countries like China are embracing virtual healthcare solutions, indicating a shifting landscape towards accessible and convenient consumer healthcare options. The awareness about lifestyle diseases is notably driving market growth, although factors such as the widespread presence of counterfeit pharmaceuticals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The awareness about lifestyle diseases is notably driving the market growth. There has been a significant transformation in the lifestyles and dietary patterns of consumers over recent decades, driven by urbanization and consumerism. This shift has led to increased consumption of artificial and synthetic foods. Additionally, sedentary lifestyles and imbalanced diets have contributed to the rise in lifestyle-related diseases such as stroke, heart disease, obesity, Type 2 diabetes, and atherosclerosis.

Consumers are increasingly cognizant of the health issues associated with lifestyle diseases. Consequently, they are gradually embracing dietary supplements, sports nutrition, and weight management products. The global consumer healthcare market is experiencing rapid growth, with numerous players introducing value-added offerings across various segments such as allergy relief, digestive health, feminine care, cough and cold remedies, flu treatments, pain relief, and dietary supplements. This growing awareness of lifestyle diseases is expected to boost the demand for over-the-counter (OTC) pharmaceuticals, driving market growth and trends during the forecast period.

Significant Market Trends

The accelerated use of online resources in the market is a key trend in the consumer healthcare industry. Health-related information is easily available on the Internet. Therefore, self-medication with over-the-counter (OTC) medicines is becoming popular. Moreover, manufacturers and retailers of these products are shifting to online platforms for better visibility. These platforms have options such as live chats. Therefore, the online sale of these products helps pharmaceutical companies leverage financial growth.

The use of online resources and self-medication increased further during the COVID-19 pandemic. Several governments imposed lockdowns, which led people to stock over-the-counter (OTC) medications such as paracetamol and ibuprofen for symptom relief. This propelled the demand for these products. Therefore, the global market is expected to grow at a positive rate during the forecast period.

Major Market Challenge

The widespread presence of counterfeit pharmaceuticals is challenging the industry's growth. Counterfeit medications often misrepresent their origin, legitimacy, or efficacy. They may have insufficient or no amount of active ingredients. They are often processed improperly within the body. Moreover, these medications have compounds that are not listed on the label or are packaged and labeled incorrectly.

Counterfeit pharmaceuticals pose a major threat to public health and can result in failure of a treatment regimen or even death. For instance, Mexico is a major market for counterfeit drugs, which are valued at an estimated average of USD 650 million per year. They account for about 10% of the total drug sales in the country. Thus, the sales of counterfeit consumer healthcare may impede the growth of the market during the forecast period.

Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major Consumer Healthcare Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

BioGaia AB - The company offers consumer health products such as Immune Active Kids and Protectis Mum and Protectis tabs for gut comfort. 

The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market Companies, including:

  • Abbott Laboratories
  • Amway Corp.
  • BASF SE
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Chr Hansen Holding AS
  • Danone SA
  • Eisai Co. Ltd.
  • Glanbia plc
  • GlaxoSmithKline Plc
  • Herbalife International of America Inc.
  • Himalaya Global Holdings Ltd.
  • Johnson and Johnson Services Inc.
  • Kellogg Co.
  • Koninklijke DSM NV
  • Nestle SA
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The consumer healthcare landscape is shaped by factors like disposable income, fostering a rise in OTC generics and per capita spending. With a surge in startups and established players like Boehringer Ingelheim GmbH, product launch and approval activities are frequent, emphasizing branding and alignment with current trends. Amid estimations and restraints, benchmarking guides strategies across application areas spanning personal healthcare products, cosmetics, and consumer medical devices. Facilitated by telemedicine and health apps, convenience and accessibility drive engagement, particularly in addressing cardiovascular disease through diagnosis and on-demand treatments, supported by innovative solutions like behavioral coaching apps. Product launches by companies such as Cooper Consumer Health encompass a variety of offerings from creams to nutritional supplements, while partnerships with entities like CVC Capital Partners optimize distribution through wholesalers, distributors, and online pharmacies sourced from internet sources.

Blood vessels are central to cardiovascular health, where the prevalence rate of diseases prompts demand for treatments on-demand, including sprays and other remedies. Amidst fierce competitors, healthcare expenditures escalate, driven by factors like an aging population and increasing healthcare needs in developing nations. Pharmaceutical prescriptions span diverse categories, from gastrointestinal products to skin products, mineral and vitamin supplements, and even sleeping aids. Additionally, a plethora of offerings includes ophthalmic products, sports supplements, and various nutritional components like amino acids, probiotics, and omega-3 fatty acids, catering to holistic wellbeing. Traditional remedies, such as herbal products, complement modern treatments for conditions like allergy care, often in convenient forms like nasal sprays, antihistamine medication, and eye drops, ensuring comprehensive paediatric care.

Segment Overview

The market growth analysis report forecasts market growth by revenue at global, regional, & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook
    • OTC pharmaceuticals
    • Dietary supplements
  • Distribution Channel Outlook 
    • Offline
    • Online
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Consumer Healthcare Market Scope

Market Report Coverage

Details

Page number

164

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.84%

Market growth 2023-2027

USD 189.13 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

6.35

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Glanbia plc, GlaxoSmithKline Plc, Herbalife International of America Inc., Himalaya Global Holdings Ltd., Johnson and Johnson Services Inc., Kellogg Co., Koninklijke DSM NV, Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, and Sanofi

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our market trends and analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the market and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Asia, Europe, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about Companies
  • Comprehensive analysis of factors that will challenge the growth of market Companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global consumer healthcare market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global consumer healthcare market 2017 - 2021 ($ billion)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
    • 4.3 Distribution channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distribution channel Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 OTC pharmaceuticals - Market size and forecast 2022-2027
      • Exhibit 34: Chart on OTC pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on OTC pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on OTC pharmaceuticals - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on OTC pharmaceuticals - Year-over-year growth 2022-2027 (%)
    • 6.4 Dietary supplements - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Dietary supplements - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Dietary supplements - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Dietary supplements - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Dietary supplements - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 46: Chart on Comparison by Distribution Channel
      • Exhibit 47: Data Table on Comparison by Distribution Channel
    • 7.3 Offline - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
    • 7.4 Online - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Distribution Channel
      • Exhibit 56: Market opportunity by Distribution Channel ($ billion)
      • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Japan - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ billion)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 107: Abbott Laboratories - Overview
              • Exhibit 108: Abbott Laboratories - Business segments
              • Exhibit 109: Abbott Laboratories - Key news
              • Exhibit 110: Abbott Laboratories - Key offerings
              • Exhibit 111: Abbott Laboratories - Segment focus
            • 12.4 Amway Corp.
              • Exhibit 112: Amway Corp. - Overview
              • Exhibit 113: Amway Corp. - Product / Service
              • Exhibit 114: Amway Corp. - Key news
              • Exhibit 115: Amway Corp. - Key offerings
            • 12.5 BASF SE
              • Exhibit 116: BASF SE - Overview
              • Exhibit 117: BASF SE - Business segments
              • Exhibit 118: BASF SE - Key news
              • Exhibit 119: BASF SE - Key offerings
              • Exhibit 120: BASF SE - Segment focus
            • 12.6 Bayer AG
              • Exhibit 121: Bayer AG - Overview
              • Exhibit 122: Bayer AG - Business segments
              • Exhibit 123: Bayer AG - Key news
              • Exhibit 124: Bayer AG - Key offerings
              • Exhibit 125: Bayer AG - Segment focus
            • 12.7 BioGaia AB
              • Exhibit 126: BioGaia AB - Overview
              • Exhibit 127: BioGaia AB - Business segments
              • Exhibit 128: BioGaia AB - Key news
              • Exhibit 129: BioGaia AB - Key offerings
              • Exhibit 130: BioGaia AB - Segment focus
            • 12.8 Boehringer Ingelheim International GmbH
              • Exhibit 131: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 133: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
            • 12.9 Chr Hansen Holding AS
              • Exhibit 136: Chr Hansen Holding AS - Overview
              • Exhibit 137: Chr Hansen Holding AS - Business segments
              • Exhibit 138: Chr Hansen Holding AS - Key news
              • Exhibit 139: Chr Hansen Holding AS - Key offerings
              • Exhibit 140: Chr Hansen Holding AS - Segment focus
            • 12.10 Danone SA
              • Exhibit 141: Danone SA - Overview
              • Exhibit 142: Danone SA - Business segments
              • Exhibit 143: Danone SA - Key news
              • Exhibit 144: Danone SA - Key offerings
              • Exhibit 145: Danone SA - Segment focus
            • 12.11 Eisai Co. Ltd.
              • Exhibit 146: Eisai Co. Ltd. - Overview
              • Exhibit 147: Eisai Co. Ltd. - Business segments
              • Exhibit 148: Eisai Co. Ltd. - Key offerings
              • Exhibit 149: Eisai Co. Ltd. - Segment focus
            • 12.12 GlaxoSmithKline Plc
              • Exhibit 150: GlaxoSmithKline Plc - Overview
              • Exhibit 151: GlaxoSmithKline Plc - Business segments
              • Exhibit 152: GlaxoSmithKline Plc - Key news
              • Exhibit 153: GlaxoSmithKline Plc - Key offerings
              • Exhibit 154: GlaxoSmithKline Plc - Segment focus
            • 12.13 Johnson and Johnson Services Inc.
              • Exhibit 155: Johnson and Johnson Services Inc. - Overview
              • Exhibit 156: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 157: Johnson and Johnson Services Inc. - Key news
              • Exhibit 158: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 159: Johnson and Johnson Services Inc. - Segment focus
            • 12.14 Koninklijke DSM NV
              • Exhibit 160: Koninklijke DSM NV - Overview
              • Exhibit 161: Koninklijke DSM NV - Business segments
              • Exhibit 162: Koninklijke DSM NV - Key news
              • Exhibit 163: Koninklijke DSM NV - Key offerings
              • Exhibit 164: Koninklijke DSM NV - Segment focus
            • 12.15 Nestle SA
              • Exhibit 165: Nestle SA - Overview
              • Exhibit 166: Nestle SA - Business segments
              • Exhibit 167: Nestle SA - Key news
              • Exhibit 168: Nestle SA - Key offerings
              • Exhibit 169: Nestle SA - Segment focus
            • 12.16 Pfizer Inc.
              • Exhibit 170: Pfizer Inc. - Overview
              • Exhibit 171: Pfizer Inc. - Product / Service
              • Exhibit 172: Pfizer Inc. - Key news
              • Exhibit 173: Pfizer Inc. - Key offerings
            • 12.17 Sanofi
              • Exhibit 174: Sanofi - Overview
              • Exhibit 175: Sanofi - Business segments
              • Exhibit 176: Sanofi - Key news
              • Exhibit 177: Sanofi - Key offerings
              • Exhibit 178: Sanofi - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              consumer healthcare market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis